Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Aline Meirhaeghe

Aline Meirhaeghe

University of Lille France France

Carlo Gaetano

Carlo Gaetano

Goethe Unicersity Germany Germany

Etheresia Pretorius

Etheresia Pretorius

University of Pretoria South Africa South Africa

Brandon Davis

Brandon Davis

Davis Psychological Services USA

Christine Comera

Christine Comera

National Institute of Agronomic Research (INRA) France

Jeffrey L. Kibler

Jeffrey L. Kibler

Nova Southeastern University USA

Heidi Dowse

Heidi Dowse

The Salvation Army Aged Care Plus Sydney Australia

Malcolm Carruthers

Malcolm Carruthers

Centre for Mens Health UK

Euro Endocrinology 2018

About Conference


Prevalence of endocrine disorders is increasing among all ages in Europe, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. About 60 million people with diabetes in the European Region and about 10.3% of men and 9.6% of women aged 25 years and over.

High blood glucose kills about 3.4 million people worldwide, annually. More than 80% of these deaths occur in low- and middle-income countries, and almost half are people aged less than 70 years. Diabetes deaths will be doubled between 2005 and 2030, as per WHO projections.

Medical doctors, patients and health care providers consider the prevention of endocrine disorders as an essential tool to improve the general health status of the population. According to a recent statistical survey, the proportions of people suffering from the disease are expected to increase in future. Realizing this imperative, Conference Series is set to organize 13th European Diabetes and Endocrinology Congress to be held during November 26-27, 2018 at Dublin, Ireland with a view to promote awareness and enhance research aiming in developing solutions for the challenges encountered.

Organizing Committee invites the participants from all over the globe to take part in this annual flagship conference with the theme “Outlining the forefront research in the field of Diabetes and Endocrinology”. Euro Endocrinology Conference 2018 will focus on the latest and exciting innovations in all areas of Diabetes and Endocrinology research and aims in proclaim knowledge and share new ideas amongst Endocrinologists, Diabetes expertise, Researchers, Professors, Scientific communities, Counselors, Delegates, Students, Business professionals and Executives. The Conference will have space for institutions and/or companies to present their services, products, innovations and research results.

 

In support of improving patient care, this activity has been planned and implemented by Conference Series and Center for Education Development (CED). CED is jointly accredited by the Accreditation Council for Pharmacy Education (ACPE), the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Dublin, Ireland

Dublin is often regarded as one of Europe’s most coveted destinations. This beautiful and vibrant city has all the ingredients to make the Congress a joyful and memorable event. “In Dublin’s fair city, where the girls are so pretty, I first set my eyes on sweet Molly Malone …” is one of the oldest & traditional songs & also the unofficial anthem of the Irish, “Molly Malone”, earning the capital of Republic of Ireland the nickname, “The Fair City”. With numerous magical tales of the vibrant history, one gets lost in this beautiful city, which comes as a breath of fresh air, especially with its deep inter-connected links between the history & present. Colorfully decorated churches, lively cafés and world-class music venues as well as friendly people and genuine hospitality combine to make your stay memorable. The benefit of visiting Ireland in November is you are between fall and winter seasons, so are more likely to have it to yourself, with the summer-fall visitors long gone and the winter visitors are yet to arrive. The Emerald Isle is famous for its cuisine, pubs, literary figures, picturesque villages and golf heritage, all of which can be part of a November visit. Ireland is not really a weather-driven destination in any case.

Sessions/Tracks

Diabetes Therapeutics and Diagnostics

The incidence rate of diabetes is exceptionally high across the globe, fueled by reducing physical activities and unhealthy diet. According to IMARC’s report, compared to Type-1 diabetes, Type-2 diabetes represents the more prevalent type, accounting for the majority of all diagnosed diabetes cases. Urban areas dominate rural areas in the number of diabetes patients and females presently account for the majority of the total diabetes patients. Despite the general down climate of the economy and healthcare, there has been great progress in the advancement of diabetes knowledge, treatment and prevention in recent years. This progress continues of a daily basis, with scientific advances being announced at an exponential rate. New therapeutic products are being introduced regularly and the pipeline is now full of new diabetes therapeutics in development. Never before, in the history of medicine, has the outlook for diabetes treatment and prevention looked so promising. The diabetes drugs segment dominated the endocrinology drugs market and accounted for more than 86% of the market share during 2015. At an annual growth rate (CAGR) of 4.4%, from 2016 to 2021, World diabetes market projected to reach $155 billion by 2021 from $125 billion.

                                   

                                                    Fig: Global Diabetes Devices Market by Geography.

 

Endocrinology and Metabolism

The tracks discusses concerning the dire increase within the prevalence of assorted hormone-related medical conditions like diabetes, hypogonadism, hypothyroidism and hyperthyroidism. Interventions in medicine create an enormous impact on lifetime of patients with endocrine diseases. This endocrinology conference discusses the role vie by each medical and surgical interventions in practice of endocrinology. Endocrinology is branch of medication wherever treatment is as near ideal as doable. For people with endocrine deficiencies, medical intervention in form of replacement with hormones generated by recombinant technologies is a perfectly natural treatment. Hormone excess is additionally being evaluated and treated with passing precise surgical interventions with minimal morbidity. The global endocrinology market is poised to grow steadily at a CAGR of more than 6% over the forecast period, as per Technavio. The Global Endocrine Testing Market will grow strong during the forecast period 2017 to 2025. According to several analyses, nearly 415 million individuals were affected by diabetes in 2015 and this number is very likely to touch 642 million by 2040. 

                                      

                                                          Fig: Molecular Diagnostics Market Forecast.

 

Hormone Dependent Cancers

Hormones not just influence breast and glandular cancer (2 most common hormone-dependent cancers), however even have a serious impact on less common hormone-sensitive malignancies (e.g. ovary, testes, endometrium) additionally human cancers recently discovered to be hormone sensitive (e.g. lung, liver). Developing a way to more precisely treat and forestall hormone-dependent cancers is of essential importance given the significant impact these malignancies have on human health and also the economic burden of disease. An in depth understanding of hormone action in regulating diverse cellular processes, cancer phenotypes and drug responsiveness is essential for the development of effective and well tolerated treatment strategies. A recent advance in the field has been the understanding and exploitation of pathway cross-talk in hormone dependent cancer, which will also compose a part of the conference. Distribution of breast cancer therapeutics through retail pharmacies has become the most popular medium. In 2016, retail pharmacies held the largest market share and will grow at considerable rate over the forecast timeframe owing to increased number of pharmacies in both developed and developing regions. Breast Cancer Therapeutics Market is poised to cross USD 28 billion by 2024, as per the recent research.

                             

                                                         Fig: Cancer Therapeutics Market Forecast.

 

Thyroid Disorders

Thyroid cancer is a metastatic tumor of the thyroid gland. It is comparatively uncommon compared to other cancers. Within USA, it is calculated that in 2016 close to 64,000 new patients will be diagnosed with thyroid cancer, compared to more than 240,000 patients with breast cancer and 135,000 patients with colorectal cancer. However, fewer than 2,000 patients die of thyroid cancer annually. In 2013 over 630,000 patients were living with thyroid cancer within USA. Recent epidemiological data from WHO suggests that there are more than 750 million cases globally with a thyroid disorder. Increasing focus by government organizations and private agencies like WHO and pharmaceutical companies, to create awareness of thyroid deficiency is fuelling the market growth. Levothyroxine and Cytomel are the most selling drugs in the thyroid deficiency treatment market.

                                                 

                                           Fig: Thyroid Gland Disorders Treatment Market by Geography.

 

Adrenal Disorders

There are several diseases and dysfunctions related to the adrenal. One among them is the growth of tumors on the glands. These tumors are benign or cancerous and might throw off the proper production of hormones. A tumor that causes the gland to make an excessive amount of secretion is termed a functioning tumor, whereas a tumor that cause’s insufficient hormone secretion is termed a nonfunctioning tumor. Approximately 4 to 12 out of 1 million people develop a type of adrenal tumor called adrenocortical carcinoma, according to American Society of Clinical Oncology. Addison’s disease affects one hundred ten to one hundred forty four of every one million people in developed countries. Cushing's syndrome is uncommon which is affecting about 10 to 15 out of every 1 million people each year. CAH is one among the foremost common genetic disorders, poignant roughly 1 in 100 people, whereas mild CAH is much more common than severe CAH. Severe CAH is estimated to occur in 1 in 14,000 people. Although a large number of people have pituitary tumors (up to 20% of the world's population), most of these tumors are not cancerous, do not cause symptoms, and are never diagnosed.

                                               

                                                       Fig: Progressive responsibility the adrenal glands

 

Pituitary and Neuroendocrinology

With a prevalence of about 10% on MR imaging in the general population, Pituitary tumors are more common than typically thought.  At the same time, many endocrinologists and internists may not have sufficient exposure to deal confidently with a variety of pituitary disorders.  If not properly treated, pituitary disorders may result in significant morbidity and lower life expectancy.  The pituitary is the center of human sexuality and reproduction. Other parts of the body do most of the work but the pituitary initiates and controls the processes. Because of hormones about 30 and 40% of the population suffers sexual dysfunction at some time in their life. Endocrinology Society studies have reported that CDI is more prevalent in children and older adults (>80 years of age). Primary tumors of the pituitary fossa result in CDI in 50% of children and 30% of adults, while head trauma to the posterior pituitary gland accounts for 2% of cases in children and 17% in adults. Hypopituitarism is listed as a rare disorder by the National Institutes of health. To date, there are no US-based studies on the prevalence and incidence of hypopituitarism.  One published report indicated it affects less than 200,000 individuals in the US.  And the 2010 National Hospital Discharge Survey reported 17,101 US inpatient hospital visits with anhypopituitarism/ hypopituitarism) as one of any listed diagnoses, and 749 visits with this as the primary diagnosis. In addition, the reported average hospital stay was 5.4 days.

                          

                                     Fig: Global Neuroendocrine Tumor Treatment Market Share, By Drug

 

Reproductive Endocrinology

It is estimated that globally 15% of couples affected by Infertility, amounting to 48.5 million couples. Males are found to be solely responsible for 20-30% of infertility cases and contribute to 50% of cases overall. The problem affects around one in seven couples in the U.K, which translates as approximately 3.5 million people. When the balance of many different hormones goes wrong at any point in the body, infertility is a potential result. There are several health conditions that are specific to the endocrine (hormonal) system of the body. Hormone imbalances are not solely a female fertility problem. Male fertility will reduce if there is a problem with testosterone levels among different hormones produced by the pituitary and thyroid glands. Female infertility will result from hormone problems, physiological problems and lifestyle or environmental factors. Infertility occurs in around 12% of women in the UK. In around thirty percent of patients the cause for hyperprolactinemia is not known.

                                       

                                                                Fig: Percentage Cause of Infertility

 

Osteoporosis and Bone Health

A healthy skeletal system with strong bones is crucial to quality and healthy life. But too many people suffer from bone disease and fractures, much of which could be prevented. An estimated ten million people in USA over age 50 have osteoporosis, while another 34 million are at risk. Every year around 1.5 million people suffer an osteoporotic-related fracture which causes downward spiral in physical and mental health. Nearly twenty percent of aged people who suffer a hip fracture die within a year. One out of every two women over 50 will have an osteoporosis-related fracture in their lifetime, with risk of fracture increasing with age. In USA, more than 53 million people either already possess osteoporosis or are at high risk due to low bone mass.

                                     

                                                           Fig: Effect of physical activity on bone mass

 

Endocrine Tumours and Neoplasia

It is estimated that over 12,000 Americans are diagnosed with an endocrine tumor every year. Over 1,500 people in the United States are diagnosed with Merkel cell skin cancer each year. Most of the people diagnosed with the disease are over age 50, and 90% of cases occur in white people. The 5-year survival rate of people with Merkel cell cancer is about 60%. MEN1 (Multiple endocrine neoplasia type 1) is a hereditary condition associated with tumors of the endocrine glands. MEN1 was originally known as Wermer syndrome. It is estimated that about 1 in 30,000 people has MEN1. According to studies, about 10% of people with MEN1 do not have a family history of the condition; they have a de novo (new) mutation in the MEN1 gene.

                                                           

                                                                     Fig: Distribution of PNET's

Cardiovascular Endocrinology

Increase in worldwide prevalence of obesity-associated diabetes, dyslipidemia and hypertension makes it imperative that endocrinologists, cardiologists and others have a forum for new treatment and therapeutic developments. Patients with diabetes are at increased risk of developing a number of serious microvascular and macrovascular complications. Across all ages, the relative risk of developing cardiovascular disease (CVD) is ∼2 for patients with diabetes compared with the general population and CVD contributes significantly to the increased, albeit decreasing over time, mortality rate. Still, CVD accounts for up to 50% of deaths in patients with diabetes. The American Heart Association (AHA) predicts that by 2030, 40.5% of the US population will likely have some form of a CVD, and that the direct cost of treating CVDs will triple from $273 billion in 2010 to $818 billion in 2030; with indirect costs expected to increase from $172 billion to $276 billion in the same time period.

Pediatric Endocrinology

It is being acknowledged that the leading problem for infants and children was birth defects, prematurity/low birth weight, maternal complications of pregnancy, sudden infant death syndrome and respiratory distress syndrome. The rise in incidence of Type 2 diabetes in adolescents appears to parallel the very worrisome rise in excess body weight and obesity. There are a number of general pediatricians around the world. As per the records it is being acknowledged that globally 7.62% are registered pediatricians with specific specialty. USA is said to be one of the top most countries having a large number of pediatricians.  Global burden of pediatric mortality is increasing drastically every year. WHO estimates that 8.8 million deaths occur annually among infants and children < 5 years of age. 3.8 million in the first 30 days of life 36% of neonatal deaths due to infectious diseases. Nearly 9 million children under five die every year. Reflecting this imperative, we believe that professionally-oriented education in to cure pediatric diseases is essential in the training of clinicians and clinical academics who will provide the future leadership in this key area for global health.

Obesity and Metabolism

Obesity is a complex disease that is associated with a number of comorbidities, exaggerated mortality and reduced quality of life. With the rise in obesity among the older adult population, the cost burden is predicted to increase substantially: the combined medical costs associated with treatment of obesity-related diseases, cardiovascular diseases, and diabetes in the US alone have been estimated to increase by $48-66 billion/year from 2010 through 2030 according to Endocrine Facts and Figures. In a 2011 study of 300 Filipino-Americans, representative of the second largest Asian subgroup in the United States, a modified definition of MetS was used to take account of the ethnic-specific body structure: elevated waist circumference was outlined as 88 cm in women and 90 cm in men. In participants 35 to 75 years of age, 18.3% of the participants (21.1% of males and 15.7% of females) met the threshold for MetS. The prevalence of MetS was significantly less than the NHANES values for 2009-2010.

To Collaborate Scientific Professionals around the World

Conference Date November 26-27, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Diabetes & Metabolism Journal of Thyroid Disorders & Therapy Journal of Steroids & Hormonal Science

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos

Keytopics

  • Acquired Partial Lipodystrophy
  • Addison Disease
  • Adrenal Carcinoma
  • Adrenal Crisis
  • Adrenal Crisis In Emergency Medicine
  • Adrenal Disease And Pregnancy
  • Adrenal Hemorrhage
  • Adrenal Incidentaloma
  • Alcoholic Ketoacidosis
  • Amenorrhea
  • Anabolic Steroid Use And Abuse
  • Anaplastic Thyroid Carcinoma
  • Androgen Excess
  • Androgenetic Alopecia
  • Anovulation
  • Autoimmune Thyroid Disease And Pregnancy
  • Beriberi (Thiamine Deficiency)
  • Blood Glucose Monitors
  • Bone Markers In Osteoporosis
  • Bullous Disease Of Diabetes
  • C-11 Hydroxylase Deficiency
  • C-17 Hydroxylase Deficiency
  • Calcinosis Cutis
  • Calciphylaxis
  • Carotenemia
  • Cerebral Salt-Wasting Syndrome
  • Cholesterol Embolism
  • Congenital Adrenal Hyperplasia
  • Cyclooxygenase Deficiency
  • Diabetes Insipidus
  • Diabetes Mellitus And Pregnancy
  • Diabetic Foot Infections
  • Diabetic Ketoacidosis
  • Diabetic Neuropathy
  • Diabetic Retinopathy
  • Diabetic Ulcers
  • Diffuse Toxic Goiter
  • Dysfunctional Uterine Bleeding
  • Endocannabinoids
  • Endocrine Myopathies
  • Endogenous Cushing Syndrome
  • Euthyroid Hyperthyroxinemia
  • Euthyroid Sick Syndrome
  • Exocrine Pancreatic Insufficiency
  • Exogenous Cushing Syndrome
  • Fallopian Tube Reconstruction
  • Familial Hypercholesterolemia
  • Follicle-Stimulating Hormone Abnormalities
  • Follicular Thyroid Carcinoma
  • Generalized Lipodystrophy
  • Glucagonoma
  • Glucose Intolerance
  • Glucose-6-Phosphatase Deficiency
  • Glycogen Storage Diseases Types I-VII
  • Goiter
  • Gonadotropin-Releasing Hormone Deficiency In Adults
  • Graves Disease
  • Growth Hormone Deficiency
  • Growth Hormone Replacement In Older Men
  • Gynecomastia
  • Hashimoto Thyroiditis
  • High HDL Cholesterol (Hyperalphalipoproteinemia)
  • Hirsutism
  • Hurthle Cell Carcinoma
  • Hypercalcemia
  • Hypercalcemia In Emergency Medicine
  • Hyperchloremic Acidosis
  • Hyperglucagonemia
  • Hyperglycemia And Hypoglycemia In Stroke
  • Hyperkalemia
  • Hyperkalemia In Emergency Medicine
  • Hypermagnesemia In Emergency Medicine
  • Hypernatremia
  • Hypernatremia In Emergency Medicine
  • Hyperosmolar Hyperglycemic State
  • Hyperparathyroidism
  • Hyperphosphatemia
  • Hyperprolactinemia
  • Hyperthyroidism
  • Hyperthyroidism, Thyroid Storm, And Graves Disease
  • Hypertriglyceridemia
  • Hyperuricemia
  • Hypoalbuminemia
  • Hypocalcemia
  • Hypoglycemia
  • Hypokalemia
  • Hypokalemia In Emergency Medicine
  • Hyponatremia
  • Hyponatremia In Emergency Medicine
  • Hypoparathyroidism
  • Hypophosphatemia
  • Hypopituitarism (Panhypopituitarism)
  • Hyporeninemic Hypoaldosteronism
  • Hypothyroidism
  • Hypothyroidism And Myxedema Coma
  • Inborn Errors Of Metabolism
  • Infection In Patients With Diabetes Mellitus
  • Insulin Pumps
  • Insulin Resistance
  • Insulinoma
  • Iodine Deficiency
  • Ketosis-Prone Type 2 Diabetes
  • Lactic Acidosis
  • Lecithin-Cholesterol Acyltransferase Deficiency
  • Lichen Amyloidosis
  • Lithium-Induced Goiter
  • Localized Lipodystrophy
  • Low HDL Cholesterol (Hypoalphalipoproteinemia)
  • Low LDL Cholesterol (Hypobetalipoproteinemia)
  • Luteal Phase Dysfunction
  • Luteinizing Hormone Deficiency
  • Macular Amyloidosis
  • McCune-Albright Syndrome
  • Medullary Thyroid Carcinoma
  • Metabolic Acidosis In Emergency Medicine
  • Methylmalonic Acidemia
  • Milk-Alkali Syndrome
  • Multiple Endocrine Neoplasia Type 1
  • Myxedema Coma Or Crisis
  • Nasal And Sublabial Approaches To The Pituitary
  • Necrobiosis Lipoidica
  • Neonatal Hypoglycemia
  • Neoplasms Of The Endocrine Pancreas
  • Neurological Manifestations Of Thyroid Disease
  • Nodular Localized Cutaneous Amyloidosis
  • Nontoxic Goiter
  • Nutrition In Patients With Diabetes
  • Obesity
  • Ochronosis
  • Osteoma Cutis
  • Osteopetrosis
  • Osteoporosis In Solid Organ Transplantation
  • Ovarian Insufficiency
  • Ovotesticular Disorder Of Sexual Development
  • Papillary Thyroid Carcinoma
  • Parathyroid Carcinoma
  • Pheochromocytoma
  • Pituitary Apoplexy
  • Pituitary Disease And Pregnancy
  • Pituitary Macroadenomas
  • Pituitary Microadenomas
  • Polygenic Hypercholesterolemia
  • Porphyria Cutanea Tarda
  • Pretibial Myxedema
  • Primary Aldosteronism
  • Prolactin Deficiency
  • Prolactinoma
  • Propionic Acidemia
  • Protein-Energy Malnutrition
  • Pseudo-Cushing Syndrome
  • Pseudohypoglycemia
  • Pseudohypoparathyroidism
  • Pyridoxine Deficiency
  • Pyruvate Carboxylase Deficiency
  • Pyruvate Kinase Deficiency
  • Respiratory Acidosis
  • Respiratory Alkalosis
  • Riboflavin Deficiency
  • Riedel Thyroiditis
  • Scurvy
  • Somogyi Phenomenon
  • Subacute Thyroiditis
  • Substernal Thyroid Goiter
  • Thyroid Dysfunction Induced By Amiodarone Therapy
  • Thyroid Hormone Toxicity
  • Thyroid Nodule
  • Thyroid Storm
  • Thyroid-Associated Orbitopathy
  • Thyrotoxic Storm Following Thyroidectomy
  • Thyroxine-Binding Globulin Deficiency
  • Toxic Nodular Goiter
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Type 2 Multiple Endocrine Neoplasia
  • Type I Polyglandular Autoimmune Syndrome
  • Type Ia Glycogen Storage Disease
  • Type Ib Glycogen Storage Disease
  • Type II Glycogen Storage Disease (Pompe Disease)
  • Type II Polyglandular Autoimmune Syndrome
  • Type III Glycogen Storage Disease
  • Type III Polyglandular Autoimmune Syndrome
  • Type IV Glycogen Storage Disease
  • Type V Glycogen Storage Disease
  • Type VI Glycogen Storage Disease
  • Type VII Glycogen Storage Disease
  • VIPomas
  • Vitamin A Deficiency
  • Vitamin D Deficiency And Related Disorders
  • Vitamin E Deficiency
  • Vitamin K Deficiency
  • Wermer Syndrome (MEN Type 1)